1.
Borowiec A, Właszczuk A, Olakowska E, Lewin-Kowalik J. TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients. Medicine and Pharmacy Reports [Internet]. 9Jun.2022 [cited 6Jul.2022];. Available from: https://medpharmareports.com/index.php/mpr/article/view/2187